Selective inhibitors of apoptotic caspases: Implications for novel therapeutic strategies

Drug Discovery Today

Volumn 6, Issue 2, 2001, Pages 85-91

  Nuttall, Mark E ^a   Lee, Dennis ^a   McLaughlin, BethAnn ^b   Erhardt, Joseph A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME;

APOPTOSIS; CARTILAGE CELL; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DRUG ACTIVITY; ENZYME INHIBITION; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PREVENTION; REVIEW;

EID: 0035140058     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01601-9     Document Type: Review

References (48)

1. Caspases: enemies within
2. Mammalian caspases: structure, activation, substrates, and functions during apoptosis
3. Proteases to die for
4. Inhibition of human caspases by peptide-based and macromolecular inhibitors
5. Non-specific effects of methyl ketone peptide inhibitors of caspases
6. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
7. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
8. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
9. Differential requirement for caspase 9 in apoptotic pathways in vivo
10. Defects in regulation of apoptosis in caspase-2-deficient mice
11. A combinatorial approach defines specificities of members of the caspase family and granzyme B
12. Caspase inhibitors
13. Emerging roles of caspase-3 in apoptosis
14. Caspases: killer proteases
15. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
16. Conformationally constrained inhibitors of caspase-1 (interleukin-1b converting enzyme) and of the human CED-3 homolog caspase-3 (CPP32, apopain)
17. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
18. Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro
19. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology
20. Apoptosis in human osteoarthritic cartilage: a microscopy report
21. Differential expression of the protooncogene Bcl-2 in normal and osteoarthritic human articular cartilage
22. Soluble Fas ligand in joints of patients with rheumatoid arthritis and osteoarthritis
23. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. Correlation of morphology and metabolic data
24. Parathyroid hormone-related peptide and the parathyroid hormone/parathyroid hormone-related peptide receptor in skeletal development
25. Apoptosis of chondrocytes in transgenic mice lacking collagen II
26. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis
27. Neuroprotection by the inhibition of apoptosis
28. Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches
29. Inhibition of interleukin 1b converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
30. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury
31. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in rat
32. Cytochrome c release and caspase activation following traumatic axonal injury
33. Caspase-3 mediated neuronal death after traumatic brain injury in rats
34. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines
35. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
36. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
37. Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons
38. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
39. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity
40. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons
41. A system for characterizing cellular and molecular events in programmed neuronal cell death
42. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support
43. Need for caspase in apoptosis of trophic factor-deprived PC12 cells
44. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity
45. Caspases: intracellular signaling by proteolysis
46. Apoptosis in the rheumatic diseases
47. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants